Pyxis Diagnostics
Pyxis Diagnostics develops a novel computational biology platform focused on predicting patient response to Immuno-Oncology (IO) treatments and discovering new drug combinations for non-responders. Their technology integrates immune parameters, gene expression profiling, and machine learning to analyze the inter-cellular communication network within tumors. By comparing network patterns between responders and non-responders, Pyxis identifies predictive biomarkers and potential new drug targets to overcome resistance mechanisms, aiming to improve treatment outcomes for cancer patients.
Pyxis Diagnostics
Pyxis Diagnostics develops a novel computational biology platform focused on predicting patient response to Immuno-Oncology (IO) treatments and discovering new drug combinations for non-responders. Their technology integrates immune parameters, gene expression profiling, and machine learning to analyze the inter-cellular communication network within tumors. By comparing network patterns between responders and non-responders, Pyxis identifies predictive biomarkers and potential new drug targets to overcome resistance mechanisms, aiming to improve treatment outcomes for cancer patients.